Filing Details

Accession Number:
0001140361-19-018103
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-08 09:43:36
Reporting Period:
2019-10-04
Accepted Time:
2019-10-08 09:43:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
97517 Texas Pacific Land Trust TPL Oil Royalty Traders (6792) 750279735
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
905084 R Allan Tessler 2500 Moose-Wilson Road
Wilson WY 83014
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Sub-Share Certificates Of Proprietary Interest Acquisiton 2019-10-04 500 $603.86 10,830 No 4 P Indirect ART-FGT Family Partners Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect ART-FGT Family Partners Limited
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Sub-Share Certificates Of Proprietary Interest 1,300 Indirect Tessler Family LP
Footnotes
  1. The Issuer's Sub-share Certificates of Proprietary Interest, par value $.03-1/3 (the "Shares") are held by ART-FGT Family Partners Limited, a Wyoming limited partnership ("ART-FGT LP"). The general partner of ART-FGT LP is Tessler FMC, LLC, a Wyoming limited liability company ("Tessler LLC"). Mr. Tessler and his spouse, Frances G. Tessler, are the members of Tessler LLC. Andrea Tessler and Karla Tessler, daughters of Mr. Tessler, are the managers of Tessler LLC. Mr. Tessler is a partner and controls ART-FGT LP. ART-FGT LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to such Shares. Mr. Tessler disclaims beneficial ownership of the 10,830 Shares held by ART-FGT LP for purposes of Section 16 of the Securities Exchange Act of 1934 (the "Act"), except for his pecuniary interest therein.
  2. No transaction is reported. The amount of Shares held indirectly through Tessler Family LP is included for information purposes only. Shares are held by Tessler Family LP. The general partner of Tessler Family LP is Apres Vous, LLC, a Wyoming limited liability company ("Apres LLC"). Andrea Tessler, Karla Tessler and Christopher Tessler, the children of Mr. Tessler, are the members of Apres LLC. Andrea Tessler and Karla Tessler are the managers of Apres LLC. Mr. Tessler is a partner and controls Tessler Family LP. Tessler Family LP and Mr. Tessler may be deemed to share voting power and dispositive power with respect to the such Shares. Mr. Tessler disclaims beneficial ownership of the 1,300 shares held by Tessler Family LP for purposes of Section 16 of the Act, except for his pecuniary interest therein.
  3. SoftVest Advisors LLC, a Delaware limited liability company ("SoftVest Advisors"), Horizon Kinetics LLC, a Delaware limited liability company ("Horizon"), ART-FGT LP and Tessler Family Limited Partnership, a Wyoming limited partnership ("Tessler Family LP") have entered into a Cooperation Agreement, dated May 15, 2019 (the "Cooperation Agreement"). As a result of the Cooperation Agreement, SoftVest Advisors, SoftVest L.P., a Delaware limited partnership ("SoftVest LP"), Eric L. Oliver ("Mr. Oliver"), ART-FGT LP, Tessler Family LP, Mr. Tessler and Horizon may be deemed to have formed a "group" pursuant to Rule 13d-5(b)(1) promulgated under the Act.
  4. Each of the parties to the Cooperation Agreement may also be deemed to share voting power and dispositive power with respect to each other party's Shares as a result of the covenants and restrictions set forth in the Cooperation Agreement. Therefore, each of the parties to the Cooperation Agreement may be deemed to beneficially own all Shares beneficially owned by the other parties to the Cooperation Agreement, but each party to the Cooperation Agreement disclaims any beneficial ownership or pecuniary interest with respect to the Shares held by the other parties. The Shares in this Form 3 do not include the Shares owned by SoftVest LP, SoftVest Advisors, Mr. Oliver and Horizon.